NURON BIOTECH, INC.

Profile

Company Names

NURON BIOTECH, INC.

Addresses

1 EAST UWCHLAN AVENUE, SUITE 302, EXTON, PA 19341

Phone Numbers

610 968 6700

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$52,705,658.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2014-01-31 
$22,705,658.00 
$35,718,166.00 
$13,012,508.00 
Equity 
1
2012-12-19 
$30,000,000.00 
$30,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARK 
 
AMBROSE 
EXECUTIVE OFFICER
NURON BIOTECH, INC.
GREGORY 
 
BROWN 
DIRECTOR
EDGE HEALTH INITIATIVES, LLC   |  NURON BIOTECH, INC.   |  CHARLOTTE ANGEL FUND II, LLC   |  AQUESTIVE THERAPEUTICS, INC.   |  MEMGEN, LLC   |  MEMGEN, INC.   |  CURVEBEAM AI LTD   |  MATRIX CAPITAL MANAGEMENT FUND (OFFSHORE) LTD.
GREGORY 
B. 
BROWN 
DIRECTOR
COWEN HEALTHCARE ROYALTY PARTNERS II, L.P.   |  VANDERBILT OVERFLOW GP, LLC   |  VANDERBILT CAPITAL GP II, LLC   |  NURON BIOTECH, INC.   |  INVUITY, INC.   |  CALADRIUS BIOSCIENCES, INC.   |  PHARMACOPHOTONICS, INC.
WARREN 
D. 
COOPER 
EXECUTIVE OFFICER, DIRECTOR
NURON BIOTECH, INC.
TODD 
 
DAVIS 
DIRECTOR
LIFELOCK, INC.   |  NURON BIOTECH, INC.   |  LIGAND PHARMACEUTICALS INC   |  TEARSCIENCE, INC.   |  PALVELLA THERAPEUTICS, INC.   |  KADENWOOD LLC   |  KADENWOOD, INC.   |  CAROMONT PARTNERS, LLC   |  SIGNING DAY SPORTS, INC.   |  QENTA INC.   |  RAD GOLF, INC.   |  BEETLEJUICE FIRST NATIONAL TOUR LLC   |  CHROMOCELL THERAPEUTICS CORP   |  PELTHOS THERAPEUTICS INC.
TODD 
C. 
DAVIS 
DIRECTOR
COWEN HEALTHCARE ROYALTY PARTNERS II, L.P.   |  VANDERBILT OVERFLOW GP, LLC   |  VANDERBILT CAPITAL GP II, LLC   |  SUNEVA MEDICAL INC.   |  NURON BIOTECH, INC.   |  PRECISION THERAPEUTICS INC
VITHALBHAI 
D. 
DHADUK 
DIRECTOR
NURON BIOTECH, INC.
WENDY 
 
DICICCO, CPA 
EXECUTIVE OFFICER
NURON BIOTECH, INC.
WENDY 
 
DICOCCO, CPA 
EXECUTIVE OFFICER
NURON BIOTECH, INC.
RICHARD 
 
DINOVITZ 
EXECUTIVE OFFICER
NURON BIOTECH, INC.
SHANKAR 
 
MUSUNURI 
EXECUTIVE OFFICER, DIRECTOR
NURON BIOTECH, INC.   |  IOGENETICS LLC   |  OCUGEN, INC.   |  OCUGEN, INC.
MUKESHBHAI 
 
PATEL 
DIRECTOR
NURON BIOTECH, INC.
MATTHEW 
Q. 
REBER 
DIRECTOR
NURON BIOTECH, INC.
ANDREW 
 
ROMBERGER, ESQ. 
EXECUTIVE OFFICER
NURON BIOTECH, INC.
ANDREW 
L. 
ROMBERGER, ESQ. 
EXECUTIVE OFFICER
NURON BIOTECH, INC.
VIJAY 
 
TAMMARA, PH.D. 
EXECUTIVE OFFICER
NURON BIOTECH, INC.
DAVID 
 
ZENG, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
NURON BIOTECH, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-02-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-31 
2013-01-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
JMP SECURITIES LLC
22208